Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.010
+0.010 (0.25%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Cytek Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$7.00
Upside
+74.56%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +49.63% | Mar 19, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +99.50% | Mar 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $8.5 | Buy | Maintains | $8 → $8.5 | +111.97% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +99.50% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8.5 | Buy | Maintains | $10 → $8.5 | +111.97% | May 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +149.38% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +149.38% | Feb 29, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $9 | Buy | Initiates | $9 | +124.44% | Dec 14, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +74.56% | Nov 9, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $8 | Hold | Maintains | $13 → $8 | +99.50% | Oct 24, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +149.38% | Oct 16, 2023 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 19, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +224.19% | May 11, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +199.25% | May 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +274.06% | Mar 7, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $14 | Hold | Maintains | $15 → $14 | +249.13% | Mar 2, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.